转移性乳腺癌的预后因素：个体化治疗的成功与挑战 - Suppr

Suppr

超能文献

Prognostic factors in metastatic breast cancer: successes and challenges toward individualized therapy.

作者信息

Andreopoulou Eleni, Hortobagyi Gabriel N

出版信息

J Clin Oncol. 2008 Aug 1;26(22):3660-2. doi: 10.1200/JCO.2008.16.1026.

DOI:10.1200/JCO.2008.16.1026

PMID:18669447

Abstract

摘要

相似文献

Prognostic factors in metastatic breast cancer: successes and challenges toward individualized therapy.转移性乳腺癌的预后因素：个体化治疗的成功与挑战

J Clin Oncol. 2008 Aug 1;26(22):3660-2. doi: 10.1200/JCO.2008.16.1026.

Update in the treatment of locally advanced breast cancer: a multidisciplinary approach.局部晚期乳腺癌治疗的进展：多学科治疗方法

Eur Rev Med Pharmacol Sci. 2007 Sep-Oct;11(5):283-9.

Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.多基因分类器、乳腺癌临床结局的预后因素及预测指标。

Adv Anat Pathol. 2009 Jul;16(4):204-15. doi: 10.1097/PAP.0b013e3181a9d4bf.

Lapatinib study supports cancer stem cell hypothesis, encourages industry research.拉帕替尼研究支持癌症干细胞假说，鼓励行业研究。

J Natl Cancer Inst. 2008 May 21;100(10):694-5. doi: 10.1093/jnci/djn168. Epub 2008 May 13.

A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.一种用于预测系统辅助化疗后淋巴结阳性乳腺癌转移风险的38基因表达特征：PACS01临床试验的基因组子研究

Breast Cancer Res Treat. 2009 Aug;116(3):509-20. doi: 10.1007/s10549-008-0250-8. Epub 2008 Nov 20.

Chemotherapy benefits nearly all early breast cancer patients.

J Natl Cancer Inst. 1997 Jun 18;89(12):838-9.

The multidisciplinary management of gastrointestinal cancer. The use of molecular markers in the diagnosis and treatment of colorectal cancer.胃肠道癌的多学科管理。分子标志物在结直肠癌诊断和治疗中的应用。

Best Pract Res Clin Gastroenterol. 2007;21(6):1071-87. doi: 10.1016/j.bpg.2007.10.002.

The influence of a gene expression profile on breast cancer decisions.基因表达谱对乳腺癌诊疗决策的影响。

J Surg Oncol. 2009 May 1;99(6):319-23. doi: 10.1002/jso.21244.

Chemotherapy for breast cancer. Part 2: Treatment of metastatic breast cancer.乳腺癌的化疗。第2部分：转移性乳腺癌的治疗。

W V Med J. 1986 Aug;82(8):267-9.

Evaluation of international treatment guidelines and prognostic tests for the treatment of early breast cancer.早期乳腺癌治疗的国际治疗指南及预后检测评估

Cancer Treat Rev. 2008 Dec;34(8):701-9. doi: 10.1016/j.ctrv.2008.04.002. Epub 2008 Oct 14.

引用本文的文献

Comprehensive analysis of gene expression profiles to identify differential prognostic factors of primary and metastatic breast cancer.对基因表达谱进行综合分析，以确定原发性和转移性乳腺癌的差异预后因素。

Saudi J Biol Sci. 2022 Jul;29(7):103318. doi: 10.1016/j.sjbs.2022.103318. Epub 2022 May 23.

Locoregional tumor burden and risk of mortality in metastatic breast cancer.转移性乳腺癌的局部区域肿瘤负荷与死亡风险

NPJ Precis Oncol. 2022 Apr 5;6(1):22. doi: 10.1038/s41698-022-00265-9.

Kallikrein 11 Down-regulation in Breast Carcinoma: Correlation With Prognostic Parameters.激肽释放酶 11 在乳腺癌中的下调：与预后参数的相关性。

In Vivo. 2021 Nov-Dec;35(6):3233-3243. doi: 10.21873/invivo.12618.

Serum Levels of Il-12 and Il-23 in Breast Cancer Patients Infected with : A Case-Control Study.感染的乳腺癌患者血清白细胞介素-12和白细胞介素-23水平：一项病例对照研究

Iran J Parasitol. 2020 Oct-Dec;15(4):466-474. doi: 10.18502/ijpa.v15i4.4850.

A Psychosocial Genomics Pilot Study in Oncology for Verifying Clinical, Inflammatory and Psychological Effects of Mind-Body Transformations-Therapy (MBT-T) in Breast Cancer Patients: Preliminary Results.一项肿瘤学领域的心理社会基因组学试点研究，用于验证身心转变疗法（MBT-T）对乳腺癌患者的临床、炎症和心理影响：初步结果。

J Clin Med. 2021 Jan 3;10(1):136. doi: 10.3390/jcm10010136.

Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry).初发转移性乳腺癌患者原发灶切除对生存的影响（GEICAM/El Alamo 登记研究）。

Sci Rep. 2019 Dec 27;9(1):20081. doi: 10.1038/s41598-019-55765-9.

The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases.转移性乳腺癌患者血清 Tau 蛋白水平的预后价值及其与脑转移的相关性。

BMC Cancer. 2019 Jan 30;19(1):110. doi: 10.1186/s12885-019-5287-z.

Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients.血清HER2细胞外结构域、S100β和CA 15-3水平是转移性乳腺癌患者的独立预后因素。

BMC Cancer. 2016 Jul 7;16:428. doi: 10.1186/s12885-016-2448-1.

An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patients.转移性乳腺癌的内部和外部验证预后评分：对2269例患者的分析。

Ann Oncol. 2014 Mar;25(3):633-638. doi: 10.1093/annonc/mdt539. Epub 2013 Dec 23.

Sequential Metastatic Breast Cancer Chemotherapy: Should the Median be the Message?序贯转移性乳腺癌化疗：中位数应该是信息吗？

Front Public Health. 2013 Nov 11;1:49. doi: 10.3389/fpubh.2013.00049. eCollection 2013.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验